GRANULOMATOUS INTERSTITIAL NEPHRITIS: COULD IT BE TUBERCULOSIS?

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/65b5986087060da28e5f6c47bd084347.pdf
GRANULOMATOUS INTERSTITIAL NEPHRITIS: COULD IT BE TUBERCULOSIS?

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Sibov
Cristina
Sibov Cristina cristina.vobis@gmail.com Tours University Hospital Centre Nephrology Tours France *
Nolwenn Rabot N.RABOT@chu-tours.fr Tours University Hospital Centre Nephrology/Pathology Tours France -
Alexandre Fillon a.fillon@arauco.fr Tours University Hospital Centre Nephrology Tours France -
-
-
-
-
-
-
-
-
-
-
-
-

Granulomatous interstitial nephritis (GIN) is a rare histologic diagnosis, caused by drugs, infections, auto immune and inflammatory disorders. Drugs and sarcoidosis are found mainly in the Western world while the tuberculous origin is prevalent in India. Tuberculosis is the most common infectious etiology of GIN. While destructive urinary tuberculosis is a well described condition, there has been a growing number of tuberculous GIN of unclear mechanism, without bacteriologic evidence.  

We describe a 28-year-old female patient, a laboratory technician in a mycobacteriology laboratory, with a history of untreated asymptomatic Crohn disease who presented with AKI without proteinuria.  

The patient had a history of Mesalazine and cyclosporine treatment for Crohn disease, stopped for 3 years at the time of the AKI. She took Paracetamol occasionally and denied taking over the counter medication such as non-steroidal anti-inflammatory drugs. She complained of easy bruising, menorrhagia and presented with multiple spontaneous ecchymoses of the legs. The laboratory results on admission were significant for creatinine of 230μmol/l, polyclonal hypogammaglobulinemia and anti-ANA 1/320. The rest of the autoimmune panel was negative, including serum complement, which was not depleted. There were no changes in electrolytes. The ACE was negative. The interferon-gamma release assay (IGRA) was uncertain. The kidney biopsy showed non-necrotizing granulomatous interstitial nephritis. Chest Xray and whole-body PET scanner were negative. Though asymptomatic, Crohn disease was thought to be the cause of the GIN and a TNFα inhibitor was started with 1mg/kg of Prednisolone tapered after 2 months. The creatinine decreased to a plateau of 150µmol/l. Five months after cessation of the corticoids, the patient developed a new episode of AKI without proteinuria. The etiologic tests were repeated and the IGRA came back positive. Anti-TNFα inhibitor antibodies were also found. The eye exam was normal. A second biopsy was performed and found GIN with severe glomerulosclerosis. Ziehl Nielsen, culture and PCR mycobacteria came back negative on the kidney biopsy. The patient received 2 months of anti-tuberculous quadruple therapy then 4 months of double therapy. The corticoids were reintroduced at 1mg/kg a day for a month with progressive tapering over 6 months. The creatinine regressed progressively. Given the work of the patient, a declaration was made for recognition of the probable tuberculous GIN as an occupational disease. At one year after the end of the treatment, the creatinine stays stable at 145µmol/l. 

This case shows multiple confounding factors that could explain the GIN. First, the history of Crohn disease, but asymptomatic at the time of the AKI. Second, the treatment by TNFα inhibitors that could explain the second episode of AKI but didn’t work because of anti-TNF antibodies. Finally, the IGRA, which was initially uncertain, became positive after starting anti-TNF treatment, with further deterioration in renal function. The diagnosis of tuberculosis is presumed given the improvement in renal function after anti-tuberculosis treatment and stability after discontinuation of corticosteroid therapy. 

More studies are needed to explore the mechanisms of tuberculous GIN.  

Kewords